Australian (ASX) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Feb 06, 2025

Discover Australian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the ASX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
VLS
Vita Life Sciences
AU$1.901.1%-2.6%AU$104.9mn/aPE11.3xn/a4.7%
CTE
Cryosite
AU$0.740%14.6%AU$36.4mn/aPE19.8xn/a2.7%
EZZ
EZZ Life Science Holdings
AU$1.90-12.0%258.5%AU$88.7mAU$5.45PE12.9xE17.9%1.6%
CSL
CSL
AU$269.86-3.8%-11.5%AU$132.1bAU$326.79PE31.1xE12.8%1.6%
CUV
Clinuvel Pharmaceuticals
AU$11.47-5.2%-28.3%AU$576.4mAU$28.23PE16.1xE26.2%0.4%
MVP
Medical Developments International
AU$0.8020.3%-14.9%AU$74.9mAU$3.33PS2.7xE91.2%0%
ACR
Acrux
AU$0.0320%-46.7%AU$12.5mn/aPS2.5xE91.8%0%
VIT
Vitura Health
AU$0.074-5.1%-69.2%AU$43.0mn/aPE12.3xn/a0%
Page 1 of 1